Anna L Olsen

1.2k total citations
9 papers, 964 citations indexed

About

Anna L Olsen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anna L Olsen has authored 9 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anna L Olsen's work include DNA Repair Mechanisms (5 papers), PARP inhibition in cancer therapy (4 papers) and Cancer therapeutics and mechanisms (2 papers). Anna L Olsen is often cited by papers focused on DNA Repair Mechanisms (5 papers), PARP inhibition in cancer therapy (4 papers) and Cancer therapeutics and mechanisms (2 papers). Anna L Olsen collaborates with scholars based in United Kingdom, United States and Netherlands. Anna L Olsen's co-authors include Peter J. McHugh, Alison E. Cowper, John I. Bell, Gavin Screaton, Rusung Tan, Xiao-Ning Xu, Andrew J. McMichael, Adrian L. Harris, Alan V. Boddy and Christopher J. Jones and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Anna L Olsen

9 papers receiving 946 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna L Olsen United Kingdom	7	727	535	213	124	95	9	964
Julia Boshuizen Netherlands	8	582 0.8×	625 1.2×	225 1.1×	112 0.9×	72 0.8×	11	952
Farah Rehman United Kingdom	12	743 1.0×	734 1.4×	92 0.4×	110 0.9×	169 1.8×	22	1.1k
Jessica Frankum United Kingdom	14	843 1.2×	697 1.3×	80 0.4×	184 1.5×	146 1.5×	21	1.1k
Ahrum Min South Korea	16	634 0.9×	635 1.2×	72 0.3×	123 1.0×	73 0.8×	36	957
Eva Schut Netherlands	13	879 1.2×	707 1.3×	201 0.9×	228 1.8×	269 2.8×	15	1.3k
Sabrina Giavara Italy	4	1.1k 1.5×	826 1.5×	92 0.4×	168 1.4×	237 2.5×	5	1.4k
Kaiming Sun United States	9	448 0.6×	685 1.3×	268 1.3×	78 0.6×	98 1.0×	20	1.1k
Mei‐Kuang Chen United States	12	527 0.7×	912 1.7×	348 1.6×	131 1.1×	51 0.5×	24	1.2k
Steven M. Walker United Kingdom	10	691 1.0×	355 0.7×	269 1.3×	95 0.8×	36 0.4×	30	1.0k
Denarda Dangaj Laniti Switzerland	15	367 0.5×	703 1.3×	544 2.6×	186 1.5×	100 1.1×	31	1.1k

Countries citing papers authored by Anna L Olsen

Since Specialization

Citations

This map shows the geographic impact of Anna L Olsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna L Olsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna L Olsen more than expected).

Fields of papers citing papers by Anna L Olsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna L Olsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna L Olsen. The network helps show where Anna L Olsen may publish in the future.

Co-authorship network of co-authors of Anna L Olsen

This figure shows the co-authorship network connecting the top 25 collaborators of Anna L Olsen. A scholar is included among the top collaborators of Anna L Olsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna L Olsen. Anna L Olsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Ronson, George E., Ann Liza Piberger, Martin R. Higgs, et al.. (2018). PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation. Nature Communications. 9(1). 746–746. 171 indexed citations

Olsen, Anna L, et al.. (2012). Quantitative Analysis of Survivin Protein Expression and Its Therapeutic Depletion by an Antisense Oligonucleotide in Human Lung Tumors. Molecular Therapy — Nucleic Acids. 1. e30–e30. 6 indexed citations

Talbot, Denis, Malcolm Ranson, Michael Lahn, et al.. (2010). Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study. Clinical Cancer Research. 16(24). 6150–6158. 74 indexed citations

Bhagwat, Nikhil R., Anna L Olsen, Anderson T. Wang, et al.. (2009). XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair. Molecular and Cellular Biology. 29(24). 6427–6437. 113 indexed citations

Talbot, D C, Anna L Olsen, Valérie André, et al.. (2009). Pharmacodynamic (PD) evaluation of LY2181308 in patients with metastatic malignancies. Journal of Clinical Oncology. 27(15_suppl). 3507–3507. 6 indexed citations

Plummer, Ruth, Christopher J. Jones, Mark R. Middleton, et al.. (2008). Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors. Clinical Cancer Research. 14(23). 7917–7923. 298 indexed citations

Plummer, Elizabeth Ruth, Mark R. Middleton, Christopher J. Jones, et al.. (2005). Temozolomide Pharmacodynamics in Patients with Metastatic Melanoma: DNA Damage and Activity of Repair Enzymes O6-Alkylguanine Alkyltransferase and Poly(ADP-Ribose) Polymerase-1. Clinical Cancer Research. 11(9). 3402–3409. 83 indexed citations

Martin‐Rendon, Enca, et al.. (2002). New Methods to Titrate EIAV-Based Lentiviral Vectors. Molecular Therapy. 5(5). 566–570. 29 indexed citations

Screaton, Gavin, Xiao-Ning Xu, Anna L Olsen, et al.. (1997). LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proceedings of the National Academy of Sciences. 94(9). 4615–4619. 184 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact